Prescription drug · ANDA
Plerixafor NDC 70771-1776
Plerixafor 24 mg/1.2mL · Injection · Subcutaneous · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1776-1 | 70771177601 | 1 VIAL, SINGLE-USE in 1 CARTON (70771-1776-1) / 1.2 mL in 1 VIAL, SINGLE-USEMarketed from Jul 28, 2023 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Plerixafor
- Generic name (nonproprietary)
- plerixafor
- Active ingredients
- Plerixafor — 24 mg/1.2mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 208980
- Marketing start
- Listing expires
- Other FDA classes
- Increased Hematopoietic Stem Cell Mobilization (Physiologic effect)
- Identifiers
- Product ID 70771-1776_41b76e97-b780-4fc8-b073-13bf155ad8a5SPL ID 41b76e97-b780-4fc8-b073-13bf155ad8a5SPL set ID 43df348a-d7f2-4f14-8131-c916679a98ebRxCUI 828700UNII S915P5499N
- Pharmacologic class
- Hematopoietic Stem Cell Mobilizer
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470771177601followed by a unit qualifier and the quantityPackage 70771-1776-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 208980
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Plerixafor | Plerixafor 24 mg/1.2mL | InjectionSubcutaneous | Zydus Pharmaceuticals USA Inc. | 70710-1208 |